CTLA4 and hepatocellular carcinoma: In the context of HCC, CTLA-4 exerts its suppressive effects by curtailing the activity of tumor-infiltrating lymphocytes, thereby facilitating tumor immune evasion and contributing to the progression of the malignancy (Figure 3).